All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry

TBK1/IKKε-IN-1(compound 1)

CAS number:1893397-65-3    molecular formula:C28H31N7O3

overview

compound introduction

TBK1/IKKε-IN-5 (compound 1) 是一种 TANK-binding kinase 1 (TBK1) 和 IκB kinase-ε (IKKε/IKK-i) 的双重抑制剂,对于TBK1和IKKε的IC50值分别为1.0 nM和5.6 nM。TBK1 /IKKε被抑制可增强对PD-1阻断的反应,从而有效地预测了体内的肿瘤反应。 Information TBK1/IKKε-IN-1 (compound 1) is a dual inhibitor ofTANK-binding kinase 1 (TBK1)andIκB kinase-ε (IKKε/IKK-i)with IC50 of 1.0 nM and 5.6 nM for TBK1 and IKKε, respectively. TBK1/IKKε inhibition enhances response to PD-1 blockade, which effectively predicts tumor response in vivo. Targets TBK1 (Cell-free assay); IKKε (Cell-free assay) 1.0 nM; 5.6 nM In vitro TBK1/IKKε-IN-1(compound 1) effectively blocks immune suppressive cytokine elaboration by CT26 cell line spheroids, without cytotoxic effects, and enhances secretion of IL-2 and IFN-γ from purified CD4+ and CD8+ T cells from healthy human donors and IL-2 from Jurkat human T-cell leukemia cells. Ex vivo addition of TBK1/IKKε-IN-1(compound 1) to PD-1 blockade enhances killing of CT26 MDOTS, associated with decreased levels of CCL4, CCL3, and IL-1β and induction of cytokines involved in activated innate immune responses. In vivo Balb/c mice bearing CT26 tumors are treated with TBK1/IKKε-IN-1(compound 1) ± anti-PD-L1. Consistent with MDOTS profiling data, greater tumor control and longer survival is evident with TBK1/IKKε-IN-1(compound 1) + anti-PD-L1 than with either TBK1/IKKε-IN-1(compound 1) or anti-PD-L1 alone. Reimplantation of CT26 into mice with exceptional responses to combination therapy shows no growth, whereas EMT-6 implanted tumors grow normally, suggesting induction of immunologic memory of CT26 cells in mice treated with TBK1/IKKε-IN-1(compound 1) + anti-PD-L1. Therefore, MDOTS profiling effectively recapitulates the in vivo response to PD-1 blockade +/− TBK1/IKKε inhibition, highlighting the potential of ex vivo screening in MDOTS to develop combination immunotherapies. Cell Research(from reference) Cell lines:HCT116 cells, human CD4+ T cells, human CD8+ T cells Concentrations:1 μM Incubation Time:1 h, 24 h, 96 h

Specs

Chinese alias-
English aliasBenzonitrile,5-​[4-​[[4-​[4-​(3-​oxetanyl)​-​1-​piperazinyl]​phenyl]​amino]​-​1,​3,​5-​triazin-​2-​yl]​-​2-​[(tetrahydro-​2H-​pyran-​4-​yl)​oxy]​-
CAS number1893397-65-3molecular formulaC28H31N7O3
molecular weight513.59 g/molExact mass10mM in DMSO
PSA109.000 Ųlogp3.176

numbering system

No numbering system information yet

physicochemical properties

No physical and chemical property information yet

Safety information

No safety information yet

Production methods and uses

No production method and use information yet

Related

upstream information

No upstream information yet

downstream information

No downstream information yet

MSDS

Found 0 shareMSDS